Controlled release of nerve growth factor from fibrin gel

Journal of Biomedical Materials Research - Part A

Volumn 80, Issue 4, 2007, Pages 998-1002

  Bhang, Suk Ho ^a,b   Jeon, Oju ^a   Choi, Cha Yong ^b   Kwon, Yun Hee Kim ^c   Kim, Byung Soo ^a  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Controlled release; Fibrin gel; Nerve growth factor; Pheochromocytoma cell

Indexed keywords

CONTROLLED RELEASE; FIBRIN GELS; NERVE GROWTH FACTORS (NGF); PHEOCHROMOCYTOMA CELLS;

CELL CULTURE; CELLS; GELS; GROWTH KINETICS; NEUROLOGY;

PROTEINS;

FIBRIN; FIBRINOGEN; GREENPLAST; HEPARIN; NERVE GROWTH FACTOR; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE FIBER REGENERATION; NERVE INJURY;

ANIMALS; CELL DIFFERENTIATION; DELAYED-ACTION PREPARATIONS; FIBRIN; GELS; NERVE GROWTH FACTOR; NERVE REGENERATION; PC12 CELLS; RATS;

EID: 33847199321     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31050     Document Type: Article

References (22)

1. Yan Q, Elliott JL, Matheson C, Sun J, Zhang L, Mu X, Rex KL, Snider WD. Influences of neurotrophins on mammalian motoneurons in vivo. J Neurobiol 1993;24:1555-1577.
2. Kuruvilla R, Zweifel LS, Glebova NO, Lonze BE, Valdez G, Ye H, Ginty DD. A neurotrophin signaling cascade coordinates sympathetic neuron development through differential control of TrkA trafficking and retrograde signaling. Cell 2004;118:243-255.
3. Hagg T, Gulati AK, Behzadian MA, Vahlsing HL, Varon S, Manthorpe M. Nerve growth factor promotes CNS cholinergic axonal regeneration into acellular peripheral nerve grafts. Exp Neurol 1991;112:79-88.
4. Kerkhoff H, Jennekens FG. Peripheral nerve lesions: The neuropharmacological outlook. Clin Neurol Neurosurg 1993;95:103-108.
5. Lad SP, Neet KE, Mufson EJ. Nerve growth factor: Structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 2003;2:315-334.
6. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation 2002;106:2257-2262.
7. Nimni ME. Polypeptide growth factors: Targeted delivery systems. Biomaterials 1997;18:1201-1225.
8. Shibayama E, Koizumi H. Cellular localization of the Trk neurotrophin receptor family in human non-neuronal tissues. Am J Pathol 1996;148:1807-1818.
9. Gwak SJ, Choi DH, Paik SS, Lee EY, Lee KS, Kim BS. Stable hepatocyte transplantation using fibrin matrix. Biotechnol Lett 2004;26:505-508.
10. Ryu JH, Kim IK, Cho SW, Cho MC, Hwang KK, Piao H, Piao S, Lim SH, Hong YS, Choi CY, Yoo KJ, Kim BS. Implantation of bone marrow mononuclear cells using injectable fibrin matrix enhances neovascularization in infarcted myocardium. Biomaterials 2005;26:319-326.
11. Sakiyama-Elbert SE, Hubbell JA. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J Control Release 2000;69:149-158.
12. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 2001;72:101-113.
13. Cheng H, Fraidakis M, Blomback B, Lapchak P, Hoffer B, Olson L. Characterization of a fibrin glue-GDNF slow-release preparation. Cell Transplant 1998;7:53-61.
14. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg 1989;97:194-203.
15. Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, Hubbell JA, Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000;17:587-591.
16. Sakiyama SE, Schense JC, Hubbell JA. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: An example of designer matrices in tissue engineering. FASEB J 1999;13:2214-2224.
17. Oberdoerster J, Rabin RA. NGF-differentiated and undifferentiated PC12 cells vary in induction of apoptosis by ethanol. Life Sci 1999;64:267-272.
18. Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sic USA 1976;73:2424-2428.
19. Jeon O, Ryu SH, Chung JH, Kim BS. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 2005;105:249-259.
20. Sakiyama-Elbert SE, Hubbell JA. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000;65:389-402.
21. Schlessinger J, Lax I, Lemmon M. Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell 1995;83:357-360.
22. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991;64:867-869.